Skip to content

Pulse Biosciences, Inc. PLSE Net Investment in Lease

Net Investment in Lease at other companies

Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
Merit Medical Systems logo
Merit Medical SystemsMMSI
ITG
Integer HoldingsITGR
LivaNova logo
LivaNovaLIVN
Capricor Therapeutics logo
Capricor TherapeuticsCAPR

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s net investment in lease?
Pulse Biosciences, Inc. (PLSE) reported net investment in lease of $5.7M in Q1 2026.
How has Pulse Biosciences, Inc.'s net investment in lease changed year-over-year?
Pulse Biosciences, Inc.'s net investment in lease decreased by 17.2% year-over-year, from $6.89M to $5.7M.
What is the long-term trend for Pulse Biosciences, Inc.'s net investment in lease?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s net investment in lease has grown at a -8.6% compound annual growth rate (CAGR), from $9.44M to $6.01M.